Product Overview: Eurotropin 13.
Eurotropin 13.32mg 40IU is a recombinant human growth hormone (rhGH) preparation manufactured by Euro-Pharmacies for in-vitro laboratory research applications. This somatropin formulation enables researchers to investigate growth hormone receptor interactions, IGF-1 pathway modulation, and metabolic signalling mechanisms in controlled laboratory environments. The precise 40IU concentration facilitates standardised research protocols examining growth hormone’s effects on cellular metabolism, protein synthesis, and tissue development. Researchers at Stroid UK Shop utilise this preparation to study endocrine system regulation and hormone-mediated cellular responses.
Laboratory Applications
Research applications focus on studying growth hormone’s mechanisms in cellular metabolism, examining its role in protein synthesis regulation, and investigating IGF-1 mediated signalling cascades. Laboratory studies evaluate growth hormone’s effects on lipolysis, gluconeogenesis, and nitrogen retention in tissue culture models. Researchers analyse dose-response relationships in various cell lines, examining growth hormone’s influence on cellular proliferation and differentiation. The preparation supports investigations into growth hormone deficiency models and receptor binding studies. Our growth hormones collection provides comprehensive research tools for endocrine studies. Comparative studies with selective androgen receptor modulators and research peptides enhance understanding of anabolic signalling pathways.
Technical Specifications
| Parameter | Value |
|---|---|
| Active Compound | Recombinant Human Growth Hormone |
| Concentration | 13.32mg (40IU) per vial |
| Form | Lyophilised powder |
| Manufacturer | Euro-Pharmacies |
| Purity | Verify with supplier |
| Storage | 2-8°C, protected from light |
| Molecular Formula | C990H1528N262O300S7 |
Research Compliance
This product is manufactured strictly for in-vitro research and laboratory analysis only. Not approved for human consumption, therapeutic use, or clinical applications. Researchers must ensure proper laboratory protocols, safety procedures, and regulatory compliance when handling this material. All studies must be conducted within appropriate research facilities by qualified personnel.
